| (TWD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 105.93M | — |
| Operating expense | — | — |
| Net income | -28.34M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 6547.TWO returned +42.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +47.0% |
| 1 year | +42.7% |
| 5 years | -72.3% |
| 10 years | +188.1% |
| All-time high | $235.52 (May 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 6547.TWO would be worth today ›No. Medigen Vaccine Biologics Corporation has not paid a dividend in the past 12 months.
Medigen Vaccine Biologics Corporation is part of the Healthcare sector.
Medigen Vaccine Biologics Corporation has a market cap of 18.51B TWD, based on the latest quote.
